- Home
- CR vs BRKR Comparison
CR vs BRKR Comparison
Compare CR & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CR
- BRKR
- Stock Information
- Founded
- CR 1855
- BRKR 1960
- Country
- CR United States
- BRKR United States
- Employees
- CR 7300
- BRKR N/A
- Industry
- CR Metal Fabrications
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- CR Industrials
- BRKR Industrials
- Exchange
- CR Nasdaq
- BRKR Nasdaq
- Market Cap
- CR 10.9B
- BRKR 6.3B
- IPO Year
- CR N/A
- BRKR 2000
- Fundamental
- Price
- CR $191.42
- BRKR $42.00
- Analyst Decision
- CR Strong Buy
- BRKR Buy
- Analyst Count
- CR 4
- BRKR 12
- Target Price
- CR $197.75
- BRKR $54.50
- AVG Volume (30 Days)
- CR 381.1K
- BRKR 2.4M
- Earning Date
- CR 07-28-2025
- BRKR 08-05-2025
- Dividend Yield
- CR 0.48%
- BRKR 0.47%
- EPS Growth
- CR 54.50
- BRKR N/A
- EPS
- CR 5.76
- BRKR 0.52
- Revenue
- CR $2,178,600,000.00
- BRKR $3,446,100,000.00
- Revenue This Year
- CR $10.22
- BRKR $6.43
- Revenue Next Year
- CR $11.07
- BRKR $4.21
- P/E Ratio
- CR $33.35
- BRKR $80.70
- Revenue Growth
- CR 17.22
- BRKR 14.84
- 52 Week Low
- CR $127.04
- BRKR $34.10
- 52 Week High
- CR $195.00
- BRKR $72.94
- Technical
- Relative Strength Index (RSI)
- CR 69.90
- BRKR 60.72
- Support Level
- CR $190.48
- BRKR $41.21
- Resistance Level
- CR $195.00
- BRKR $43.66
- Average True Range (ATR)
- CR 3.37
- BRKR 1.60
- MACD
- CR 0.13
- BRKR 0.20
- Stochastic Oscillator
- CR 88.07
- BRKR 80.80
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.